Browse treatment - cardiology database
ACAT inhibition
active compression-decompression CPR
agents to slow down human AAA-expansion
aldosterone blockade
All mechanism
alpha-glucosidase inhibitors
angioplasty
angiotensin renin system blockade
angiotensin-Converting Enzyme Inhibitors
angiotensin-receptor blockers
anti hypertensive agent
anti inflammatory drugs
anti-anginal drugs
antiarrythmic drugs
antibiotics
anticoagulant
antidiabetic drugs
antidiabetic drugs added to metformin
antioxydants
antiplatelets drug
antithrombotics
beta-blockers
BNP guided management
calcium channel blockers
catheter ablation
catheter ablation of ventricular tachycardia
caval filter
cell-based therapies
CEPT inhibition
cholesterol lowering intervention
combined inhibition of ACE and neprilysin
complement inhibition
compression-only CPR
death and events prevention
diet
dietary salt reduction
digitalis glycosides
direct antithrombins
direct factor Xa inhibitors
direct oral anticoagulant (DAO)
diuretics
Drug eluting stent
dual antiplatelet therapy
embolic protection
endarterectomy
endovascular treatment
Exercise Therapy
fibrinolysis
foramen ovale closure
fractional-flow-reserve-guided PCI
glucose insulin potassium
glucose lowering for cardiovascular prevention
graduated compression stockings
HDL increasing drugs
heparin (UFH or LMWH)
hormonal replacement therapy
HR-slowing agents
ICD
increasing hemoglobin concentration
increasing hemoglobin concentration
inhibition of the renin-angiotensin system (ACEI or ARB)
insulin secretagogues
insulin secretagogues - DPP-4 inhibitors
insulin secretagogues - Meglitinides (glinides)
insulin secretagogues - sulfonylureas
insulin secretagogues peptides (incretins)
insulin sensitizer
insulin sensitizer - biguanides
insulin sensitizers - glitazones
insulin sensitizers - PPAR modulator
insulin therapy
intensive blood pressure control
intensive glycemic control
intensive therapy
Intravascular Brachytherapy
Late revascularisation
lifestyle intervention
LMWH
mechanical devices for thromboprophylaxis
Miscellaneous
modified resuscitation protocol
myocardial revascularization
new drug under development
New P2Y12 Inhibitors
niacin
nitrates
off-pump CABG
omega-3 fatty acids
oxygen therapy
pacemaker
PCI
PCSK9 Inhibitors
pentasaccharide
percutaneous left ventricular assist device
percutaneous left ventricular assist devices
phosphodiesterase III inhibitors
plasma homocysteine lowering intervention
polypill
pre treatment for PCI
preconditioning
prevention
primary prevention of sudden death
proton-pump inhibitors
Public Access Defibrillation
radial access
radial graft
rate control
relaxine
renin inhibitor
restenosis prevention
resynchronization (CRT) - defibrillators (ICD)
rythm control
screening for CAD
secondary prevention
SGLT2 inhibitors
spinal cord stimulation
statin
surgery
telemonitoring
thrombectomy
transcatheter aortic-valve implantation (TAVI)
transmyocardial revacularization
UFH
vasodilators therapy
vasopeptidase inhibitor
vasopressin
vasopressin antagonist
vein grafts pretreatment
weight-loss drugs
|